The Level-Funded Disruption: How Angle Health's $2.7B Valuation Exposes Legacy Payer Fragility in Small-Group Underwriting
Dr. Dereck Mush, MD, MBAMarket Watch
Healthtech public markets, stock moves and sector momentum: what the market is pricing, and what it means for companies, investors and patients.
Dr. Dereck Mush, MD, MBA
